Anti-SARS-CoV-2 monoclonal antibodies are an effective treatment to prevent progression to severe COVID-19 or hospitalization in high-risk individuals. Despite the benefits offered by monoclonal antibody treatment, early reports indicated that these therapeutics were not being widely used.
Public Health
Access up-to-date ASPE research on key public health topics including emerging and re-emerging infectious diseases, such as influenza and COVID-19; health equity; antibiotic resistance; rural health; opioids, opioid use disorder and overdose prevention; maternal health; public health and health care workforce and infrastructure; immunization and vaccines; Indian health; HIV/AIDS; tobacco; and emergency preparedness, response, and recovery. Also find data on prevention, social determinants of health, and more.
Noteworthy
HHS Initiative to Improve Maternal Health
The Department’s Action Plan lays out a vision for improving maternal health that applies a “life course” approach organized around four goals and it sets three ambitious targets to achieve this vision. Each of the four goals includes multiple objectives and action items to drive progress. The Action Plan also describes the current state of maternal health outcomes in the U.S., challenges in reducing maternal mortality and morbidity, recent efforts to improve maternal health within and beyond the federal government, and it discusses various forums in which HHS leadership sought input from key stakeholders.
Reports
Displaying 121 - 130 of 923. 10 per page. Page 13.
Advanced SearchASPE Issue Brief
Variation in use of anti-SARS-CoV-2 monoclonal antibody therapies by social vulnerability and urbanicity
Research Brief
COVID-19 Vaccination Associated with Reductions in COVID-19 Mortality and Morbidity in the United States, and an Approach to Valuing these Benefits
This ASPE Research Report models the estimated reductions in COVID-19 cases, hospitalizations, and deaths associated with COVID-19 vaccination from December 2020 through July 2021. To download the Research Report, please download the PDF to the right under “Files”. To explore our dashboard that presents the Report’s results, please see below.
ASPE Issue Brief
Medicaid After Pregnancy: State-Level Implications of Extending Postpartum Coverage
The postpartum period is increasingly recognized as a target for policy intervention to improve maternal health. The American Rescue Plan Act included an option for states to offer 12 months of postpartum Medicaid eligibility, a significant extension from the current requirement of 60 days.
Report
Medicare Beneficiaries’ Use of Telehealth in 2020: Trends by Beneficiary Characteristics and Location
This research report examines changes in Medicare fee-for-service Part B visits and use of telehealth in 2020 during the COVID-19 public health emergency (PHE) by beneficiary characteristics, provider specialty, and location. The analysis found that Medicare in-person visits dropped while telehealth visits increased significantly at the start of the pandemic.
Report
Network Adequacy for Behavioral Health: Existing Standards and Considerations for Designing Standards
Network adequacy is often defined as having enough providers within a health plan network to ensure reasonable and timely access to care. At a minimum, health plans should include a sufficient number of providers who deliver mental health and substance use disorder (SUD) services (collectively referred to in this report as behavioral health services) to support access to those services.
ASPE Issue Brief
Emergency Playbook for Federal Human Services Programs
This playbook aims to synthesize lessons learned and recommendations from existing resources, emergency management protocols, and interviews with federal program staff about responding to emergencies and disasters.
ASPE Issue Brief
U.S. Department of Health and Human Services Overdose Prevention Strategy
From 1999 through 2019, there were more than 840,000 drug overdose deaths in the United States. The crisis has continually evolved and escalated, including during the COVID-19 pandemic, when an estimated 93,000 persons lost their lives to drug overdose in 2020--approximately a 30% increase over the year prior.
Report
Addressing Uncertainty in Regulatory Impact Analysis
In 2016, the U.S. Department of Health and Human Services finalized its Guidelines for Regulatory Impact Analysis under the leadership of its Assistant Secretary for Planning Evaluation and Analytics Team. The Guidelines discuss strategies for characterizing the uncertainty in quantified effects as well as the potential impacts of non-quantified effects.
Research Brief
Drug Checking Programs in the United States and Internationally: Environmental Scan Summary
This environmental scan presents a review and synthesis of approaches and strategies adopted by drug checking programs and existing evidence on their effectiveness in changing drug use attitudes, behavior, and health outcomes. It includes studies of drug checking programs across a variety of settings in the United States and internationally.
Research Brief
Associations Between County-level Vaccination Rates and COVID-19 Outcomes Among Medicare Beneficiaries in Early 2021
The purpose of this study is to identify associations between COVID-19 infections, hospitalizations, and deaths among Medicare fee-for-service (FFS) beneficiaries and the proportion of the population fully vaccinated at the county-level between January and May 2021.